Risk and Clinical Outcomes of Acute Myocardial Infarction in Patients With Cancer: A Nationwide Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Myocardial Infarction
- Sponsor
- Samsung Medical Center
- Enrollment
- 4500000
- Locations
- 1
- Primary Endpoint
- All-cause death
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.
Detailed Description
This study will be conducted using Korean National Health Insurance Service database. Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study. Using the selected patients, current study will analyze the incidence and prognosis of acute myocardial infarction in cancer patients and the prognosis according to the treatment method for acute myocardial infarction will be compared. Primary outcome will be all-cause death. Secondary outcomes will be myocardial infarction, revascularization, hospitalization for heart failure, stroke, and clinically relevant bleeding.
Investigators
Joo Myung Lee
Associate Professor
Samsung Medical Center
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with cancer between 2002 and 2021
- •Patients who were diagnosed with acute myocardial infarction after cancer diagnosis
Exclusion Criteria
- •Patients who died during period of cancer diagnosis
Outcomes
Primary Outcomes
All-cause death
Time Frame: 2-years after diagnosis of acute myocardial infarction
All-cause death which was obtained from death certification collected by Statistics Korea at the Ministry of Strategy and Finance of South Korea
Secondary Outcomes
- Myocardial infarction(2-years after diagnosis of acute myocardial infarction)
- Revascularization(2-years after diagnosis of acute myocardial infarction)
- Stroke(2-years after diagnosis of acute myocardial infarction)
- Clinically relevant bleeding(2-years after diagnosis of acute myocardial infarction)
- Hospitalization for heart failure(2-years after diagnosis of acute myocardial infarction)